Skip to main content
×
Home

Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial

  • E. Guillemard (a1), F. Tondu (a1), F. Lacoin (a2) and J. Schrezenmeir (a3)
Abstract

Common infectious diseases (CID) of the airways and the gastrointestinal tract are still a considerable cause of morbidity and mortality in elderly. The present study examined the beneficial effect of a dairy product containing the probiotic strain Lactobacillus casei DN-114 001 (fermented product) on the resistance of free-living elderly to CID. The study was multicentric, double blind and controlled, involving 1072 volunteers (median age = 76·0 years) randomised for consumption of either 200 g/d of fermented (n 537) or control (non-fermented) dairy product (n 535) for 3 months, followed by an additional 1 month's follow-up. The results showed that, when considering all CID, the fermented product significantly reduced the average duration per episode of CID (6·5 v. 8 d in control group; P = 0·008) and the cumulative duration of CID (7 v. 8 d in control group; P = 0·009). Reduction in both episode and cumulative durations was also significant for all upper respiratory tract infections (URTI; P < 0·001) and for rhinopharyngitis (P < 0·001). This was accompanied with an increase of L. casei species in stools throughout the fermented product consumption (2–3·8 × 107 equivalents of colony-forming unit/g of stools, P < 0·001). The cumulative number of CID (primary outcome) was not different between groups nor was the CID severity, fever, pathogens' occurrence, medication, immune blood parameters and quality of life. The fermented product was safe and well tolerated. In conclusion, consumption of a fermented dairy product containing the probiotic strain L. casei DN-114 001 in elderly was associated with a decreased duration of CID in comparison with the control group, especially for URTI such as rhinopharyngitis.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial
      Available formats
      ×
Copyright
Corresponding author
*Corresponding author: E. Guillemard, fax +33 1 69 35 76 46, email eric.guillemard@danone.com
References
Hide All
1 Yoshikawa TT (2000) Epidemiology and unique aspects of aging and infectious diseases. Clin Infect Dis 30, 931933.
2 Gavazzi G & Krause KH (2002) Ageing and infection. Lancet Infect Dis 2, 659666.
3 LaCroix AZ, Lipson S, Miles TP, et al. (1989) Prospective study of pneumonia hospitalizations and mortality of U.S. older people: the role of chronic conditions, health behaviors, and nutritional status. Public Health Rep 104, 350360.
4 Djuretic T, Ryan MJ, Fleming DM, et al. (1996) Infectious intestinal disease in elderly people. Commun Dis Rep CDR Rev 6, R107R112.
5 Mouton CP, Bazaldua OV, Pierce B, et al. (2001) Common infections in older adults. Am Fam Physician 63, 257268.
6 Goodwin K, Viboud C & Simonsen L (2006) Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24, 11591169.
7 McElhaney JE (2005) The unmet need in the elderly: designing new influenza vaccines for older adults. Vaccine 23, Suppl. 1, S10S25.
8 Targonski PV, Jacobson RM & Poland GA (2007) Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine 25, 30663069.
9 Nichol KL (2003) The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. Vaccine 21, 17691775.
10 Nikolich-Zugich J (2008) Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat Rev Immunol 8, 512522.
11 Delpedro AD, Barjavel MJ, Mamdouh Z, et al. (1998) Signal transduction in LPS-activated aged and young monocytes. J Interferon Cytokine Res 18, 429437.
12 McLachlan JA, Serkin CD, Morrey-Clark KM, et al. (1995) Immunological functions of aged human monocytes. Pathobiology 63, 148159.
13 Wenisch C, Patruta S, Daxbock F, et al. (2000) Effect of age on human neutrophil function. J Leukoc Biol 67, 4045.
14 Mysliwska J, Mysliwski A, Romanowski P, et al. (1992) Monocytes are responsible for depressed natural killer (NK) activity in both young and elderly low NK responders. Gerontology 38, 4149.
15 Solana R & Mariani E (2000) NK and NK/T cells in human senescence. Vaccine 18, 16131620.
16 Riezzo G, Chiloiro M & Russo F (2005) Functional foods: salient features and clinical applications. Curr Drug Targets Immune Endocr Metabol Disord 5, 331337.
17 Jones PJ & Varady KA (2008) Are functional foods redefining nutritional requirements? Appl Physiol Nutr Metab 33, 118123.
18 Gill HS & Guarner F (2004) Probiotics and human health: a clinical perspective. Postgrad Med J 80, 516526.
19 de Vrese M & Schrezenmeir J (2008) Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol 111, 166.
20 Fukushima Y, Miyaguchi S, Yamano T, et al. (2007) Improvement of nutritional status and incidence of infection in hospitalised, enterally fed elderly by feeding of fermented milk containing probiotic Lactobacillus johnsonii La1 (NCC533). Br J Nutr 98, 969977.
21 Hickson M, D'Souza AL, Muthu N, et al. (2007) Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 335, 80.
22 Adolfsson O, Meydani SN & Russell RM (2004) Yogurt and gut function. Am J Clin Nutr 80, 245256.
23 Meydani SN & Ha WK (2000) Immunologic effects of yogurt. Am J Clin Nutr 71, 861872.
24 Nova E, Warnberg J, Gomez-Martinez S, et al. (2007) Immunomodulatory effects of probiotics in different stages of life. Br J Nutr 98, Suppl. 1, S90S95.
25 Ouwehand AC, Bergsma N, Parhiala R, et al. (2008) Bifidobacterium microbiota and parameters of immune function in elderly subjects. FEMS Immunol Med Microbiol 53, 1825.
26 Klein A, Friedrich U, Vogelsang H, et al. (2008) Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp. lactis DGCC 420 modulate unspecific cellular immune response in healthy adults. Eur J Clin Nutr 62, 584593.
27 Kaila M, Isolauri E, Soppi E, et al. (1992) Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 32, 141144.
28 Bunout D, Barrera G, Hirsch S, et al. (2004) Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly. J Parenter Enteral Nutr 28, 348354.
29 de Vrese M, Winkler P, Rautenberg P, et al. (2005) Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clin Nutr 24, 481491.
30 Turchet P, Laurenzano M, Auboiron S, et al. (2003) Effect of fermented milk containing the probiotic Lactobacillus casei DN-114001 on winter infections in free-living elderly subjects: a randomised, controlled pilot study. J Nutr Health Aging 7, 7577.
31 Aggett PJ, Antoine JM, Asp NG, et al. (2005) PASSCLAIM: consensus on criteria. Eur J Nutr 44, Suppl. 1, i5i30.
32 Farnworth ER (2008) The evidence to support health claims for probiotics. J Nutr 138, 1250S1254S.
33 Haarman M & Knol J (2006) Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving a prebiotic infant formula. Appl Environ Microbiol 72, 23592365.
34 Ware J, Kosinski M & Dewey J (2000) How to Score Version 2 of the SF-36(R) Health Survey. Lincoln, RI: QualityMetric Incorporated.
35 Chavance M, Herbeth B, Lemoine A, et al. (1993) Does multivitamin supplementation prevent infections in healthy elderly subjects? A controlled trial. Int J Vitam Nutr Res 63, 1116.
36 Graat JM, Schouten EG & Kok FJ (2002) Effect of daily vitamin E and multivitamin–mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial. JAMA 288, 715721.
37 Parra D, De Morentin BM, Cobo JM, et al. (2004) Monocyte function in healthy middle-aged people receiving fermented milk containing Lactobacillus casei. J Nutr Health Aging 8, 208211.
38 Parra MD, Martínez de Morentin BE, Cobo JM, et al. (2004) Daily ingestion of fermented milk containing Lactobacillus casei DN114001 improves innate-defense capacity in healthy middle-aged people. J Physiol Biochem 60, 8591.
39 Marcos A, Warnberg J, Nova E, et al. (2004) The effect of milk fermented by yogurt cultures plus Lactobacillus casei DN-114 001 on the immune response of subjects under academic examination stress. Eur J Nutr 43, 381389.
40 GROG – Groupes Régionaux d'Observation de la Grippe (2007) Bulletin 2007/27 – Saison grippe 2006/2007: une épidémie modeste. (Bulletin 2007/27 – 2006/2007 influenza season: a modest epidemic). http://www.grog.org/bullhebdo.php
41 Hatakka K, Savilahti E, Ponka A, et al. (2001) Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 322, 1327.
42 Cox AJ, Pyne DB, Saunders PU, et al. (2008) Oral administration of the probiotic Lactobacillus fermentum VRI-003 and mucosal immunity in endurance athletes. Br J Sports Med (Epublication ahead of print version 13 February 2009).
43 Cooper NJ, Sutton AJ, Abrams KR, et al. (2003) Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ 326, 1235.
44 Hayden FG (2004) Rhinovirus and the lower respiratory tract. Rev Med Virol 14, 1731.
45 Wald TG, Shult P, Krause P, et al. (1995) A rhinovirus outbreak among residents of a long-term care facility. Ann Intern Med 123, 588593.
46 Oozeer R, Leplingard A, Mater DD, et al. (2006) Survival of Lactobacillus casei in the human digestive tract after consumption of fermented milk. Appl Environ Microbiol 72, 56155617.
47 Rochet V, Rigottier-Gois L, Sutren M, et al. (2006) Effects of orally administered Lactobacillus casei DN-114 001 on the composition or activities of the dominant faecal microbiota in healthy humans. Br J Nutr 95, 421429.
48 Rochet V, Rigottier-Gois L, Levenez F, et al. (2008) Modulation of Lactobacillus casei in ileal and fecal samples from healthy volunteers after consumption of a fermented milk containing Lactobacillus casei DN-114 001Rif. Can J Microbiol 54, 660667.
49 Guerin-Danan C, Chabanet C, Pedone C, et al. (1998) Milk fermented with yoghurt cultures and Lactobacillus casei compared with yoghurt and gelled milk influence on intestinal microflora in health infants. Am J Clin Nutr 67, 111117.
50 Glück U & Gebbers JO (2003) Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci). Am J Clin Nutr 77, 517520.
51 Corthesy B, Gaskins HR & Mercenier A (2007) Cross-talk between probiotic bacteria and the host immune system. J Nutr 137, 781S790S.
52 Pujol P, Huguet J, Drobnic F, et al. (2000) The effect of fermented milk containing Lactobacillus casei on the immune response to exercise. Sports Med Training and Rehab 9, 209223.
53 Tiollier E, Chennaoui M, Gomez-Merino D, et al. (2007) Effect of a probiotics supplementation on respiratory infections and immune and hormonal parameters during intense military training. Mil Med 172, 10061011.
54 Boge T, Rémigy M, Vaudaine S, et al. (2009) A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine (epublication ahead of print version 15 July 2009).
55 Sherman PM, Ossa JC & Johnson-Henry K (2009) Unraveling mechanisms of action of probiotics. Nutr Clin Pract 24, 1014.
56 Bourlioux P, Koletzko B, Guarner F, et al. (2003) The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium ‘The Intelligent Intestine,’ held in Paris, June 14, 2002. Am J Clin Nutr 78, 675683.
57 Ingrassia I, Leplingard A & Darfeuille-Michaud A (2005) Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn's disease patients to adhere to and to invade intestinal epithelial cells. Appl Environ Microbiol 71, 28802887.
58 Parassol N, Freitas M, Thoreux K, et al. (2005) Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells. Res Microbiol 156, 256262.
59 Wehkamp J, Harder J, Wehkamp K, et al. (2004) NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun 72, 57505758.
60 Scholz-Ahrens KE, Ade P, Marten B, et al. (2007) Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure. J Nutr 137, 838S846S.
61 Pedone CA, Bernabeu AO, Postaire ER, et al. (1999) The effect of supplementation with milk fermented by Lactobacillus casei (strain DN-114 001) on acute diarrhoea in children attending day care centres. Int J Clin Pract 53, 179184.
62 Pedone CA, Arnaud CC, Postaire ER, et al. (2000) Multicentric study of the effect of milk fermented by Lactobacillus casei on the incidence of diarrhoea. Int J Clin Pract 54, 568571.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 66
Total number of PDF views: 313 *
Loading metrics...

Abstract views

Total abstract views: 592 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 18th November 2017. This data will be updated every 24 hours.